Canary Speech is a technology company that uses AI-driven vocal digital biomarkers for conversational speech virtual health monitoring.
Canary Speech has raised $4.1M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in January 2025.
Canary Speech's investors include Hackensack Meridian Health, Sorenson Communications, Cortes capital, SMK Corporation.
Canary Speech is headquartered in Provo, United States.
Canary Speech is a technology company that uses AI-driven vocal digital biomarkers for conversational speech virtual health monitoring.
Canary Speech is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Canary Speech — Funding & Investors." VCBacked, January 6, 2025, https://www.vcbacked.co/company/canary-speech. Accessed September 29, 2026.
VCBacked. (2025). Canary Speech — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/canary-speech
{{cite web |title=Canary Speech — Funding & Investors |url=https://www.vcbacked.co/company/canary-speech |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated